June 3rd 2021 Recently, the FDA approved an Amgen drug, sotorasib, for non-small cell lung cancer (NSCLS) with a specific mutation in a gene known as Kirsten rat sarcoma viral oncogene homolog (KRAS) in patients whose disease has worsened after treatment with chemotherapy or other medicines. This mutation accounts for 13% of NSCLS—the most common … Continue reading FDA approves lung cancer drug #MPAR
Tag: Lung cancer
Research Roundup: stem cell therapy to cure alcoholism, low calorie diet to improve lifespan and more!
Welcome to this week’s Research Roundup. These Friday posts aim to inform our readers about the many stories that relate to animal research each week. Do you have an animal research story we should include in next week’s Research Roundup? You can send it to us via our Facebook page or through the contact form … Continue reading Research Roundup: stem cell therapy to cure alcoholism, low calorie diet to improve lifespan and more!
Lung cancer immunotherapy, from PD-1 knockout mice to clinical trials
This morning many news outlets, including the BBC, covered a very promising development in lung cancer therapy; the successful clinical trial of the cancer immunotherapy Nivolumab in 582 patients with advanced lung cancer. While the extension of survival was modest in most patients, it is to be remembered that these were patients with advanced lung … Continue reading Lung cancer immunotherapy, from PD-1 knockout mice to clinical trials
Speaking of Research 